Have your say: MRFF priorities 2020-2022


To guide the Medical Research Future Fund (MRFF) Australian Medical Research and Innovation Priorities for 2020–2022, a national consultation process is underway by the Department of Health.

AusBiotech members are invited to have their say and submit their MRFF priorities 2020-2022 to AusBiotech as it develops its response. Companies and organisations with expertise in health and medical research and innovation, clinicians and health services managers, the Australian public, and consumer representatives have been invited to contribute to the broader consultation.

Submissions are open, and responses will be considered by the Australian Medical Research Advisory Board. The Priorities are then considered by the Minister for Health before the Commonwealth Government decides on the disbursement of funding from the MRFF.

The consultation process aims to ensure the MRFF targets national health priorities for better health outcomes. Determining future health priorities is about considering the burden of disease in Australians and the need to enhance the translation of research into clinical practice.

Australia’s health and medical researchers are world-class, and the MRFF drives investment into the sector to deliver practical benefits of medical research and innovation to all Australians.

The landmark $20 billion MRFF was established as an endowment fund to provide a sustainable source of funding for vital medical research and is the single largest boost in health and medical research funding in Australia’s history.

AusBiotech is developing a response and invites its Members to submit their priorities to Juliana Potulic, Policy and Programmes Manager, by Monday 5 October.